COPD and type 2 diabetes
(Bentham Science Publishers) COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity. In this review article, a team of researchers from USA discuss the studies demonstrating the associations between COPD and type 2 diabetes, underlying pathophysiology and recommended therapeutic approach in the management of patients with coexisting COPD and diabetes. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 23, 2019 Category: International Medicine & Public Health Source Type: news

COPD space about to have another drug — this time from a Morrisville concern
A recent FDA approval has one Triangle pharmaceutical company going head to head with the likes of pharma giants such as GSK – in a multi-billion dollar industry company officials believe they have the edge in. Circassia, a pharmaceutical company that calls Morrisville home to its U.S. headquarters, received FDA approval for Duaklir Pressair – a drug the treatment of patients with chronic obstructive pulmonary disea se (COPD). Circassia’s David Acheson, senior vice president of commercial… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 17, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

Leonard Nimoy’s widow warns smokers ‘you always think you have more time than you do’
Leonard Nimoy's widow Susan appeared in a new commercial for the CDC's Tips From Former Smokers campaign to warn others to quit before they come down with COPD like Nimoy did. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2019 Category: Consumer Health News Source Type: news

Can oxygen treatments help prevent neurodegenerative disease?
(Natural News) Chronic obstructive pulmonary disease (COPD) limits the amount of oxygen that reaches important parts of the body. Patients with this condition are, thus, very prone to developing neurodegenerative diseases. But a Canadian-led research team advised that giving these patients extra doses of oxygen could help prevent the onset of dementia. For their experiment, researchers from the University of... (Source: NaturalNews.com)
Source: NaturalNews.com - April 14, 2019 Category: Consumer Health News Source Type: news

10 New Drugs for Primary Care: Q1 2019
Highlights:  The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus,® and 8 more new and approved drugs. (Source: ConsultantLive)
Source: ConsultantLive - April 11, 2019 Category: Internal Medicine Authors: Sydney Jennings Tags: ADHD Asthma COPD Depression Gout Headache and Migraine HIV AIDS Source Type: news

Number of nonsmokers with COPD increasing worldwide, report says
For years, more people have been developing chronic obstructive pulmonary disease around the world, and the number of nonsmokers with the condition has risen sharply, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 10, 2019 Category: Consumer Health News Source Type: news

Spry Health Keeps Tight Focus with Loop
Spry Health’s tight focus could have significantly beneficial implications for chronic obstructive pulmonary disease (COPD)patients. The Palo Alto, CA-based company and winner of the 2018 MedTech StartUp Showdown  said it has received FDA clearance for the Loop System, a wearable that has the ability to remotely monitor patients with chronic diseases. While the device has the potential to look at other disease states, company executives said they want to have a tight focus on COPD, a chronic illness that claims more than 120,000 lives in the U.S. each year. “The blessing and ...
Source: MDDI - April 10, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Cochrane Clinical Answers
Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals.  Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA contains a clinical question, a short answer, and data for the outcomes from the Cochrane Review deemed most relevant to practising healthcare professionals. The evidence is displayed in a user-friendly tabulated format that includes narratives, data, and links to graphics.CCAs a...
Source: Cochrane News and Events - April 9, 2019 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Number of nonsmokers with COPD on the rise
(American College of Chest Physicians) The global burden of COPD is high, and prevalence of nonsmokers with COPD has been increasing. In a study to be presented at CHEST Congress Thailand 2019, researchers in Nagpur, India, sought to describe the characteristics of nonsmoking patients with COPD and to determine associated comorbidities and exposures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2019 Category: International Medicine & Public Health Source Type: news

Choose ‘green’ inhalers, where possible, NICE urges people with asthma
New patient decision aid aims to help patients do their bit for the environment Related items fromOnMedica Total number of UK asthma attacks could top 10 million, says charity Adjuvanted trivalent flu vaccine best option for over-65s Medicines linked to risk of community-acquired pneumonia Three quarters of adult COPD cases may originate in childhood High TV viewing linked to increased asthma risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 8, 2019 Category: UK Health Source Type: news

CDC: Prevalence of COPD High Among Some Nonsmokers
High prevalence observed in certain industries and occupations, including information industry (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 5, 2019 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Nursing, Pulmonology, Journal, Source Type: news

CDC: Prevalence of COPD High Among Some Nonsmokers
FRIDAY, April 5, 2019 -- The prevalence of chronic obstructive pulmonary disease (COPD) among individuals who have never smoked is high in certain industries and occupations, according to research published in the April 5 issue of the U.S. Centers... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2019 Category: Pharmaceuticals Source Type: news

CSA Medical, Inc. Receives FDA Breakthrough Device Designation and IDE Approval for its RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
BOSTON, April 3, 2019 -- (Healthcare Sales & Marketing Network) -- CSA Medical today announced that its RejuvenAir® System has been designated as a Breakthrough Device by the U.S. Food and Drug Administration (FDA) and received unconditional IDE (Inve... Devices, FDA CSA Medical, Cryospray, RejuvenAir, Chronic Bronchitis, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2019 Category: Pharmaceuticals Source Type: news

FDA clears Spry Health's remote monitoring wearable for COPD patients
The Loop System continuously collects and analyzes health data to warn providers of potential deterioration. The company says it has already inked a deal with a major health system. (Source: mobihealthnews)
Source: mobihealthnews - April 2, 2019 Category: Information Technology Source Type: news

FDA OKs Duaklir Fixed-Dose Combination Inhaler for COPD FDA OKs Duaklir Fixed-Dose Combination Inhaler for COPD
Duaklir combines aclidinium bromide and formoterol fumarate and is administered twice daily via a breath-actuated inhaler for maintenance treatment of COPD.FDA Approvals (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 2, 2019 Category: Primary Care Tags: Pulmonary Medicine News Alert Source Type: news

Medical Sequelae Impact QoL Among Individuals in Recovery
More than one-third of those in recovery from drug/alcohol use have chronic physical disease. A new study looks at prevalence of health issues by type of substance used. (Source: ConsultantLive)
Source: ConsultantLive - April 1, 2019 Category: Internal Medicine Authors: Patient Care Editorial Staff Tags: COPD Diabetes Hepatitis C Source Type: news

Are the uninsured and medicaid patients more likely to be transferred to another hospital?
This study analyzed 215,000 emergency department (ED) visits to 160 US hospitals to see if patients with the common conditions of pneumonia, chronic obstructive pulmonary disease (COPD) or asthma were more likely to be discharged from the ED or transferred to another hospital after being stabilized based on their insurance status. Researchers report differences based on insurance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 1, 2019 Category: International Medicine & Public Health Source Type: news

FDA Approves Duaklir Pressair (aclidinium bromide and formoterol fumarate) for Maintenance Treatment of Chronic Obstructive Pulmonary Disease
Oxford, UK– 1 April 2019: Circassia Pharmaceuticals plc (“Circassia” or“the Company”; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces the US Food and Drug Administration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 1, 2019 Category: Drugs & Pharmacology Source Type: news

New guidance on valproate use in women
Pan-college advice aims to reduce harm Related items fromOnMedica MHRA tightens licence restrictions on valproate for women New evidence on benzodiazepine link to Alzheimer ’s Doctors debate long-term use of psychiatric drugs All antidepressants are more efficacious than placebo Antibiotics should be restricted for COPD, says NICE (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 29, 2019 Category: UK Health Source Type: news

Abatacept for RA With COPD Safe (CME/CE)
(MedPage Today) -- No increased risks for pulmonary complications compared with other biologics (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 26, 2019 Category: Primary Care Source Type: news

Mayo Clinic first in Florida to perform endoscopic lung volume reduction
JACKSONVILLE, Fla. -- Mayo Clinic in Florida is the first medical center in the state to perform endoscopic lung volume reduction with endobronchial valves. This procedure, which recently was approved by the Food and Drug Administration (FDA), treats patients experiencing disorders associated with chronic obstructive pulmonary disease (COPD), including advanced emphysema and chronic bronchitis. Only [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - March 25, 2019 Category: Hospital Management Source Type: news

Bringing Home the Future of Medical Devices
There’s a massive shift taking place in U.S. healthcare, and too few device manufacturers are using it to their advantage. With health system costs ballooning more than $100 billion over the last five years while inpatient admissions remain flat1, health system executives are concluding that their inpatient-centric, treatment-centric business models are the wrong strategy. The inpatient setting is simply too expensive with too few patients utilizing it to effectively distribute the costs. This is causing profit margins to shrink at the same time as readmission penalties harm providers that fail to keep pa...
Source: MDDI - March 22, 2019 Category: Medical Devices Authors: Tom Dudnyk Tags: Business Source Type: news

Novartis launches COPD inhalers in China
Novartis (NYSE:NVS) has launched its Ultibro Breezhaler and Seebri Breezhaler in China for the treatment of chronic obstructive pulmonary disease. The Ultibro Breezhaler system is a once-daily fixed-dose combination of indacaterol and glycopyrronium bromide. Seebri Breezhaler is a fixed-dose formulation of glycopyrronium bromide. Get the full story at our sister site, Drug Delivery Business News. The post Novartis launches COPD inhalers in China appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Novartis Source Type: news

For RA With COPD, Abatacept is Safe
(MedPage Today) -- No increased pulmonary risks compared with other biologics (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 21, 2019 Category: Primary Care Source Type: news

Practices for Reducing COPD Hospital Readmissions Explored
Communication emphasized as well as consideration of readmission as proxy for other health factors (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 20, 2019 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Critical Care, Nursing, Pulmonology, Journal, Source Type: news

Practices for Reducing COPD Hospital Readmissions Explored
WEDNESDAY, March 20, 2019 -- Communication, implementation of guidelines, and improved identification of risk factors may help reduce chronic obstructive pulmonary disease (COPD) hospital readmissions, according to a report published in the February... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 20, 2019 Category: Pharmaceuticals Source Type: news

Non-invasive imaging technique valid for identifying small airway disease in lung
(Michigan Medicine - University of Michigan) Landmark study confirms ability of non-invasive imaging technique to identify early signs of chronic obstructive pulmonary disease (COPD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2019 Category: International Medicine & Public Health Source Type: news

Top 10 ways to naturally fight bronchitis
(Natural News) More than 11 million Americans have been diagnosed with chronic obstructive pulmonary disease (COPD) and it is classified as the third leading cause of death in America. Chronic bronchitis is closely related to COPD, but luckily for sufferers, it can be treated naturally. Sometimes, the simplest solution is a lifestyle change. For example, excessive smoking is... (Source: NaturalNews.com)
Source: NaturalNews.com - March 12, 2019 Category: Consumer Health News Source Type: news

El Camino Hospital first in California to offer new treatment for severe COPD/emphysema
(Pulmonx) El Camino Hospital today announced it is the first hospital in California to have successfully performed the new and recently Food and Drug Administration (FDA) approved lung valve treatment for patients with severe COPD/emphysema, an incurable lung disease that causes extreme breathing difficulty and constant discomfort for patients. The Zephyr ® Endobronchial Valve treatment represents a major advancement because it is the first minimally invasive procedure to help emphysema sufferers breathe easier without major surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 12, 2019 Category: International Medicine & Public Health Source Type: news

Air pollution causes 800,000 extra deaths a year in Europe
The estimate is double the number of excess deaths previously thought to be linked to air pollution Related items fromOnMedica Texting can improve flu jab uptake Solid fuel cooking linked to higher respiratory death rate COPD patients need better tailored care Worse asthma control linked to poor school work COPD risk is one in four (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 12, 2019 Category: UK Health Source Type: news

5 Qs on COPD Mortality and Quality of Life
Answers to these 5 questions on new research may have you re-thinking treatment strategies for your COPD patients. (Source: ConsultantLive)
Source: ConsultantLive - March 8, 2019 Category: Internal Medicine Authors: Leo Robert Tags: COPD Quiz Source Type: news

Exfoliation Syndrome May Up Risk for COPD
FRIDAY, March 8, 2019 -- Patients with exfoliation syndrome (XFS) may be at increased risk for chronic obstructive pulmonary disease (COPD), according to a study published in the January-February issue of Ophthalmology Glaucoma. Samuel C. Taylor,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2019 Category: Pharmaceuticals Source Type: news

ResMed buys Korean home healthcare supplier HB Healthcare
ResMed (NYSE:RMD) said today that it bought Korean home healthcare equipment supplier HB Healthcare for an undisclosed amount. San Diego-based ResMed said the acquisition is aimed at extending its decade-old footprint in South Korea to “millions more patients through HBH and its wider network of trusted distributor partners.” “ResMed has reaffirmed its leading role in Korea’s CPAP and respiratory care market, and commitment to improving millions of Koreans’ breathing and quality of life,” Resmed Korea sales & marketing director Kim Ho Kyun said in prepared remarks. “With H...
Source: Mass Device - March 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Respiratory Wall Street Beat HB Healthcare ResMed Inc. Source Type: news

COPD Tied to Higher MI Risk in HIV-Positive People
(MedPage Today) -- Higher risk seen for supply-demand mismatch as with sepsis, though mechanisms of association unclear (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 6, 2019 Category: Allergy & Immunology Source Type: news

COPD Patients at Altitude Have Better Sleep Quality With Dexamethasone COPD Patients at Altitude Have Better Sleep Quality With Dexamethasone
Preventive dexamethasone treatment improved nocturnal oxygenation in certain chronic obstructive pulmonary disease (COPD) patients traveling to high altitudes, in a randomized controlled trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 6, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Daily Aspirin Might Ease COPD Flare-Ups
Title: Daily Aspirin Might Ease COPD Flare-UpsCategory: Health NewsCreated: 3/4/2019 12:00:00 AMLast Editorial Review: 3/5/2019 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - March 5, 2019 Category: Respiratory Medicine Source Type: news

Daily Aspirin Might Ease COPD Flare-Ups
Many Americans take a daily low-dose aspirin to protect their hearts. Now it appears aspirin may also reduce flare-ups of chronic obstructive pulmonary disease (COPD). (Source: WebMD Health)
Source: WebMD Health - March 4, 2019 Category: Consumer Health News Source Type: news

COPD, ILD Patients May Not Benefit From Bilateral Lung Transplant Listing
Unrestricted lung transplant listing strategy may increase transplant rates without affecting survival (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 4, 2019 Category: Respiratory Medicine Tags: Pulmonology, Surgery, Journal, Source Type: news

Daily Aspirin Might Ease COPD Flare-Ups
MONDAY, March 4, 2019 -- Many Americans take a daily low-dose aspirin to protect their hearts. Now it appears aspirin may also reduce flare-ups of chronic obstructive pulmonary disease (COPD). In a study of COPD sufferers, researchers found that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 4, 2019 Category: General Medicine Source Type: news

COPD, ILD Patients May Not Benefit From Bilateral Lung Transplant Listing
MONDAY, March 4, 2019 -- While an unrestricted listing strategy does not seem to impact overall survival among patients with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD) awaiting lung transplant, it may increase... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 4, 2019 Category: Pharmaceuticals Source Type: news

New clues as to why non-smokers, as well as smokers, develop COPD
Researchers reveal findings that explain why some people who have never smoked develop chronic obstructive pulmonary disease. (Source: Medical Research Council General News)
Source: Medical Research Council General News - February 25, 2019 Category: Research Source Type: news

130 medicines in development for asthma, allergies and other respiratory diseases
Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40 million patients in the U.S. Furthermore, respiratory allergies affect 10 percent of children under the age of 18. Not only do these diseases impact day-to-day functioning, but they can also be life-threatening. (Source: The Catalyst)
Source: The Catalyst - February 21, 2019 Category: Pharmaceuticals Tags: Medicines in Development Asthma New Era of Medicine Source Type: news

Smoking cigarettes destroys your lungs’ ability to "self-heal"… leads to COPD
(Natural News) We’ve all heard that if you quit smoking, your lungs will repair themselves over the course of several years. In fact, the American Heart Association says that lung function starts to improve after as little as two weeks without smoking, and by nine months, breathing improves dramatically. However, this is not the case... (Source: NaturalNews.com)
Source: NaturalNews.com - February 20, 2019 Category: Consumer Health News Source Type: news

ResMed, Fisher & Paykel agree to settle all outstanding patent suits
ResMed (NYSE:RMD) and Fisher & Paykel Healthcare (NZE:FPH) said today in a joint announcement that they have reached an agreement to settle all outstanding patent infringement disputes across all global venues. While the terms of the deal remain confidential, both San Diego-based ResMed and Auckland, New Zealand-based Fisher & Paykel said it involved no payments from either party. The companies said that, moving forward, all infringement proceedings against named products will be dismissed with each party bearing its own attorney fees and costs. The settlement is effective immediately, and both compa...
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Legal News Patent Infringement Fisher & Paykel Healthcare ResMed Inc. Source Type: news

Personal Health: The Case Against Cough Medicine
Evidence is sorely lacking for the value of any over-the-counter remedy to treat most coughs. (Source: NYT Health)
Source: NYT Health - February 18, 2019 Category: Consumer Health News Authors: JANE E. BRODY Tags: Coughs Humidifiers Respiratory Diseases Chronic Obstructive Pulmonary Disease Medicine and Health Source Type: news

More needs to be done to raise awareness of lung cancer risk in people with COPD
(University of Surrey) People with chronic obstructive pulmonary disease (COPD) need more support when understanding and acting on new chest symptoms, a study in the journal Psycho-Oncology reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 18, 2019 Category: Cancer & Oncology Source Type: news

FDA goes after California stem cell doc for unapproved breast implant device
The FDA this week sent a warning letter to a Beverly Hills, Calif.-based surgeon for their marketing of an unapproved implantable device, dubbed the Pocket Protector, which the surgeon claims can prevent and treat capsular contracture, or scar tissue tightening, during breast implant procedures. In its letter, the federal watchdog also accuses the surgeon, Dr. Mark Berman, of “significant deviations from the FDA’s quality system requirements and current good manufacturing practices,” including charges related to the sterility of implantable devices. “This is not the first time the FDA has notified D...
Source: Mass Device - February 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cosmetic/Aesthetic Featured Food & Drug Administration (FDA) Stem Cells Source Type: news

Vapotherm launches Precision Flow Hi-VNI respiratory device
Vapotherm said today that it launched its next-gen Precision Flow Hi-VNI system intended to relieve respiratory stress in spontaneously breathing patients. The Exeter, N.H.-based company touted that the next-gen device features improvements to both its software and hardware intended to improve reliability. The Precision Flow Hi-VNI system is designed to deliver maskless noninvasive ventilation to patients who are spontaneously breathing to relieve respiratory distress including hypercapnia, hypoxemia and dyspnea, Vapotherm said. The company’s Precision Flow devices are intended to provide high-velocity heated, humidi...
Source: Mass Device - February 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory Vapotherm Source Type: news

Asthma-COPD Overlap: A 5-question Quiz
Take our 5-question quiz to find out what you know about the intersection of these frequently misunderstood disorders. (Source: ConsultantLive)
Source: ConsultantLive - February 12, 2019 Category: Internal Medicine Authors: Leo Robert Tags: COPD Quiz Source Type: news

Touting pricetag, Mylan launches Advair generic
Mylan (NSDQ:MYL) today announced the launch of its Wixela Inhub product, a generic for GlaxoSmithKline‘s (NYSE:GSK) Advair Diskus device, for people with asthma or chronic obstructive pulmonary disease. The company touted that its device’s list price is 70% less than Advair Diskus and 67% less than GSK’s generic. Get the full story at our sister site, Drug Delivery Business News. The post Touting pricetag, Mylan launches Advair generic appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured Food & Drug Administration (FDA) Pharmaceuticals Wall Street Beat GlaxoSmithKline plc Mylan Source Type: news